M. Monti

发表

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial

J. Marchesini, R. Ferrari, M. Valgimigli, 2012, Circulation.

Genetic determinants of on-clopidogrel high platelet reactivity

J. Marchesini, R. Ferrari, M. Valgimigli, 2011, Platelets.

Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients wit

R. Ferrari, M. Valgimigli, G. Campo, 2012, JACC. Cardiovascular interventions.

The in vitro effects of verbascoside on human platelet aggregation

J. Marchesini, R. Ferrari, G. Campo, 2012, Journal of Thrombosis and Thrombolysis.

Randomized, double‐blind comparison of effects of abiciximab bolus only vs. on‐label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting

R. Ferrari, M. Valgimigli, G. Campo, 2010, Journal of thrombosis and haemostasis : JTH.

Interventional Cardiology Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting A Randomized Multicenter Trial

J. Marchesini, R. Ferrari, M. Valgimigli, 2015 .

Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplas

J. Marchesini, R. Ferrari, M. Valgimigli, 2010, American heart journal.

rediction of 1-Year Clinical Outcomes Using the YNTAX Score in Patients With Acute ST-Segment levation Myocardial Infarction Undergoing Primary ercutaneous Coronary Intervention Substudy of the STRATEGY ( Single High-Dose Bolus Tirofiban and irolimus-Eluting Stent Versus Abciximab and Bare-Metal Ste

P. Serruys, G. Campo, G. Sarno, 2011 .

Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Me

P. Serruys, S. Garg, H. Garcia-Garcia, 2011, JACC. Cardiovascular interventions.

Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study.

L. Räber, S. Windecker, S. Rimoldi, 2018, JACC. Cardiovascular interventions.

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial

J. Marchesini, R. Ferrari, M. Valgimigli, 2012, Circulation.